Finding the Right Path

At Coltrain Medical Group, we recognize that choosing a treatment path for opioid use disorder can feel overwhelming. Medication assisted treatment, often called MAT, is one option that may improve stability when it is combined with counseling and recovery support. Our role is to explain how each medication works, set appropriate expectations, and help you decide what may fit your goals and health history.



What MAT Aims to Do

MAT uses medications with established evidence to reduce withdrawal symptoms and cravings, while therapy addresses habits, triggers, and long term recovery skills. Peer reviewed studies associate MAT with improved retention in care and lower mortality risk, which may support safer and more durable recovery. A large meta analysis reported lower death rates during periods on buprenorphine or methadone when compared with periods out of treatment.

Suboxone

Suboxone contains buprenorphine and naloxone. Buprenorphine is a partial opioid agonist, which means it activates the receptor enough to help relieve withdrawal and cravings without producing the full effect profile of opioids. Naloxone is included to deter non prescribed routes of use. Clinical reviews link buprenorphine maintenance with reduced illicit opioid use and better treatment retention when compared with placebo or taper strategies.



Sublocade

Sublocade is a monthly, extended release injection of buprenorphine. By providing a steady medication level over four weeks, it may remove the burden of daily dosing and reduce the chance of missed doses. Randomized and observational studies suggest that extended release buprenorphine can reduce opioid use and support retention in treatment programs. We consider Sublocade for people who prefer a set schedule, for those who have difficulty with daily dosing, or when consistent blood levels could support clinical goals.

Vivitrol

Vivitrol is a monthly injection of naltrexone, an opioid receptor antagonist. It does not stimulate the receptor. Instead, it blocks opioid effects, which may help prevent a return to use after detox. Evidence indicates that extended release naltrexone can lower relapse risk for some patients when it is paired with counseling and support, although successful initiation requires complete detoxification first. We discuss the advantages and the practical requirements of Vivitrol carefully, since timing and readiness after detox are important.

Choosing Among Options

Selecting Suboxone, Sublocade, or Vivitrol depends on clinical history, current medications, access to follow up, and personal preference. Some patients value the flexibility of a daily film. Others prefer a monthly injection that builds routine. We also review medical considerations, such as liver health, potential drug interactions, and prior responses to treatment. No single option is best for everyone, and plans often evolve as needs change.

How we Support Success

Medication is one part of recovery, not the whole plan. We pair MAT with counseling, relapse prevention skills, and support for mental health and social needs. We set clear goals, monitor progress, and adjust care when life changes. When setbacks occur, we respond quickly and without judgment, since early intervention may prevent a return to harmful use. More broadly, the evidence base suggests that staying engaged in treatment may improve safety and quality of life, particularly when medications are combined with ongoing support.

An Informed Next Step

If you or a loved one is considering MAT, we are ready to help you review options, understand the evidence, and choose a plan that respects your values. Research suggests that thoughtfully applied medications, used within a supportive program, may improve stability and reduce risk. Our aim is to provide careful guidance at every step, so you can build a recovery that lasts.

Please get in touch with Coltrain Medical Group as soon as possible and begin the process of reclaiming your life.